The University of Texas MD Anderson Cancer Center, Houston, TX. Eleni Efstathiou, University of Athens, Athens, Greece. Clinicians are increasingly will...vekri
was validated in 56 patients with metastatic cancer harboring CCNE1 amplification who received phase I trial therapy (A) and in 23 patients who did not receive phase I trial therapy (B) Kaplan–Meier curves estimate overall survival after initial phase I trial clinic visit, stratified by risk ...
MD Anderson Cancer Center MMS Representative(在职员工)-Houston, TX-2019年12月9日 I have worked for the company for 10 years now. I am a re-hire and this is the only company I have worked for that I have no complaints and I enjoy coming to work everyday. ...
Laboratory Medicine, MD Anderson Cancer Center, Houston, TX, USAElsevier Inc.Human ImmunologyCano P.The incidence of rare and new HLA alleles.Tissue ... P Cano - 《Human Immunology》 被引量: 2发表: 2011年 Association of inability to secure timely medical appointment and medication non-adherence...
Department of Urology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX 77030, USA * Author to whom correspondence should be addressed. Cancers2022,14(16), 3896;https://doi.org/10.3390/cancers14163896 ...